Genasense® (, oblimersen sodium G3139)

WITHDRAWN · PHASE3 · Lymphocytic Leukemia

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.